171 related articles for article (PubMed ID: 36081396)
21. [The metabolic syndrome and inflammation: actual issues of pathogenesis].
Sveklina TS; Talantseva MS; Barsukov AV
Klin Lab Diagn; 2013 Mar; (3):7-10. PubMed ID: 23808015
[TBL] [Abstract][Full Text] [Related]
22. Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women.
Park B
J Gynecol Oncol; 2022 Jul; 33(4):e35. PubMed ID: 35320886
[TBL] [Abstract][Full Text] [Related]
23. Metabolic syndrome and risk factors for cardiovascular disease in obese children: the relationship with insulin resistance (HOMA-IR).
Ferreira AP; Oliveira CE; França NM
J Pediatr (Rio J); 2007; 83(1):21-6. PubMed ID: 17183416
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase.
Battelli MG; Bortolotti M; Polito L; Bolognesi A
Redox Biol; 2019 Feb; 21():101070. PubMed ID: 30576922
[TBL] [Abstract][Full Text] [Related]
25. [Relation between sexual dysfunction and metabolic syndrome].
Zsoldos M; Pajor A; Pusztafalvi H
Orv Hetil; 2019 Jan; 160(3):98-103. PubMed ID: 30640528
[TBL] [Abstract][Full Text] [Related]
26. The Influence of the Metabolic Syndrome on Early Postoperative Outcomes of Patients With Advanced-stage Endometrial Cancer.
Bacalbasa N; Diaconu C; Iliescu L; Savu C; Savu C; Balalau C; Dimitriu M; Filipescu A; Bratu OG; Neacsu A; Cretoiu D; Halmaciu I; Balescu I
In Vivo; 2020; 34(5):2913-2917. PubMed ID: 32871832
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms behind the link between obesity and gastrointestinal cancers.
Tilg H; Moschen AR
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):599-610. PubMed ID: 25194178
[TBL] [Abstract][Full Text] [Related]
28. The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male.
Mansyur MA; Bakri S; Patellongi IJ; Rahman IA
Clin Nutr ESPEN; 2020 Feb; 35():69-74. PubMed ID: 31987123
[TBL] [Abstract][Full Text] [Related]
29. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.
Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
Trop Gastroenterol; 2013; 34(1):18-24. PubMed ID: 23923370
[TBL] [Abstract][Full Text] [Related]
30. Association of systemic inflammation with the obesity paradox in cancer: results from multi-cohort studies.
Xie H; Wei L; Zhang H; Ruan G; Liu X; Lin S; Shi J; Liu C; Zheng X; Chen Y; Shi H
Inflamm Res; 2024 Feb; 73(2):243-252. PubMed ID: 38087077
[TBL] [Abstract][Full Text] [Related]
31. Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity.
Dobson R; Burgess MI; Sprung VS; Irwin A; Hamer M; Jones J; Daousi C; Adams V; Kemp GJ; Shojaee-Moradie F; Umpleby M; Cuthbertson DJ
Int J Obes (Lond); 2016 Jan; 40(1):153-61. PubMed ID: 26271188
[TBL] [Abstract][Full Text] [Related]
32. Is there any relationship between benign endometrial pathologies and metabolic status?
Kaya S; Kaya B; Keskin HL; Kayhan Tetik B; Yavuz FA
J Obstet Gynaecol; 2019 Feb; 39(2):176-183. PubMed ID: 30286675
[TBL] [Abstract][Full Text] [Related]
33. Obesity modulation - the role in carcinogenesis.
Legakis I; Syrigos K
Anticancer Agents Med Chem; 2010 Jul; 10(6):481-90. PubMed ID: 20698826
[TBL] [Abstract][Full Text] [Related]
34. Metabolic diseases and cancer risk.
Faulds MH; Dahlman-Wright K
Curr Opin Oncol; 2012 Jan; 24(1):58-61. PubMed ID: 22123235
[TBL] [Abstract][Full Text] [Related]
35. Metabolic Syndrome Rather than Obesity Alone Is More Significant for Kidney Disease.
Bagasrawala SI; Sheth H; Shah H; Ansari R; Lakdawala M
Obes Surg; 2019 Nov; 29(11):3478-3483. PubMed ID: 31190265
[TBL] [Abstract][Full Text] [Related]
36. A single centre experience of metabolic syndrome and endometrial carcinoma: 5 years review.
Shafiee MN; Razak N; Ahmad MF; Abd Aziz N; Adeeb N
J Obstet Gynaecol; 2021 Feb; 41(2):285-289. PubMed ID: 33258710
[TBL] [Abstract][Full Text] [Related]
37. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.
Drager LF; Togeiro SM; Polotsky VY; Lorenzi-Filho G
J Am Coll Cardiol; 2013 Aug; 62(7):569-76. PubMed ID: 23770180
[TBL] [Abstract][Full Text] [Related]
38. Mannose-binding lectin in obesity with different degrees of metabolic syndrome abnormalities: association with atherogenic and metabolic traits.
Strack C; Baessler A; Wagner F; Bruxmeier J; Yaroslavskii O; Rousseva E; Loew T; Riegger G; Schmitz G; Fischer M
J Atheroscler Thromb; 2012; 19(6):539-51. PubMed ID: 22472212
[TBL] [Abstract][Full Text] [Related]
39. Metabolic syndrome and insulin resistance in obese adolescents.
Gobato AO; Vasques AC; Zambon MP; Barros Filho Ade A; Hessel G
Rev Paul Pediatr; 2014 Mar; 32(1):55-62. PubMed ID: 24676191
[TBL] [Abstract][Full Text] [Related]
40. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
Manco M
J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
